MEDICOX Co., Ltd. (KOSDAQ:054180)
South Korea
· Delayed Price · Currency is KRW 106.00
-9.00 (-7.83%)
Last updated: May 13, 2025
MEDICOX Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 30,611 | 26,875 | 20,296 | 17,449 | 16,190 | Upgrade
|
| Revenue | 30,611 | 26,875 | 20,296 | 17,449 | 16,190 | Upgrade
|
| Revenue Growth (YoY) | 13.90% | 32.42% | 16.32% | 7.78% | -26.75% | Upgrade
|
| Cost of Revenue | 28,627 | 25,022 | 19,801 | 17,015 | 14,095 | Upgrade
|
| Gross Profit | 1,984 | 1,853 | 494.97 | 433.65 | 2,095 | Upgrade
|
| Selling, General & Admin | 11,014 | 10,776 | 10,532 | 8,927 | 5,984 | Upgrade
|
| Research & Development | 2.2 | 2.4 | 2.4 | 2.4 | 1.8 | Upgrade
|
| Other Operating Expenses | 45.77 | 81.13 | 53.56 | 47.84 | 122.88 | Upgrade
|
| Operating Expenses | 12,775 | 14,764 | 14,368 | 10,621 | 6,855 | Upgrade
|
| Operating Income | -10,791 | -12,911 | -13,873 | -10,187 | -4,759 | Upgrade
|
| Interest Expense | -2,309 | -3,948 | -2,680 | -3,586 | -1,849 | Upgrade
|
| Interest & Investment Income | 267.77 | 473.77 | 278.31 | 83.59 | 28.24 | Upgrade
|
| Earnings From Equity Investments | -2,374 | -1,284 | 52.84 | -1,605 | -265.44 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.08 | -0.39 | -1.15 | -0.19 | 0.15 | Upgrade
|
| Other Non Operating Income (Expenses) | 1,046 | -2,615 | -14,301 | -966.08 | -194.03 | Upgrade
|
| EBT Excluding Unusual Items | -14,159 | -20,285 | -30,524 | -16,261 | -7,039 | Upgrade
|
| Gain (Loss) on Sale of Investments | -4,154 | -11,837 | -8,923 | -7,663 | -1,374 | Upgrade
|
| Gain (Loss) on Sale of Assets | -3.43 | 967.91 | 3.83 | 10.47 | 46.94 | Upgrade
|
| Asset Writedown | -2,824 | -43.28 | -4,292 | - | - | Upgrade
|
| Other Unusual Items | -354.95 | 45.06 | 1,931 | -24.03 | -216.35 | Upgrade
|
| Pretax Income | -21,497 | -31,152 | -41,804 | -23,938 | -8,583 | Upgrade
|
| Income Tax Expense | -72.46 | - | - | - | - | Upgrade
|
| Earnings From Continuing Operations | -21,424 | -31,152 | -41,804 | -23,938 | -8,583 | Upgrade
|
| Earnings From Discontinued Operations | -10.65 | -3,274 | -814.32 | - | - | Upgrade
|
| Net Income to Company | -21,435 | -34,427 | -42,619 | -23,938 | -8,583 | Upgrade
|
| Minority Interest in Earnings | - | - | - | 3.15 | - | Upgrade
|
| Net Income | -21,435 | -34,427 | -42,619 | -23,935 | -8,583 | Upgrade
|
| Net Income to Common | -21,435 | -34,427 | -42,619 | -23,935 | -8,583 | Upgrade
|
| Shares Outstanding (Basic) | 58 | 29 | 21 | 13 | 7 | Upgrade
|
| Shares Outstanding (Diluted) | 58 | 29 | 21 | 13 | 7 | Upgrade
|
| Shares Change (YoY) | 98.62% | 37.16% | 59.58% | 90.89% | 30.01% | Upgrade
|
| EPS (Basic) | -372.54 | -1188.41 | -2017.83 | -1808.37 | -1237.86 | Upgrade
|
| EPS (Diluted) | -372.54 | -1188.41 | -2017.83 | -1808.37 | -1240.00 | Upgrade
|
| Free Cash Flow | -7,000 | -9,340 | -12,855 | -8,807 | -5,755 | Upgrade
|
| Free Cash Flow Per Share | -121.66 | -322.40 | -608.65 | -665.39 | -829.97 | Upgrade
|
| Gross Margin | 6.48% | 6.90% | 2.44% | 2.48% | 12.94% | Upgrade
|
| Operating Margin | -35.25% | -48.04% | -68.35% | -58.38% | -29.40% | Upgrade
|
| Profit Margin | -70.02% | -128.10% | -209.99% | -137.17% | -53.01% | Upgrade
|
| Free Cash Flow Margin | -22.87% | -34.75% | -63.34% | -50.47% | -35.54% | Upgrade
|
| EBITDA | -8,688 | -9,940 | -10,602 | -7,978 | -2,960 | Upgrade
|
| EBITDA Margin | -28.38% | -36.98% | -52.23% | -45.72% | -18.28% | Upgrade
|
| D&A For EBITDA | 2,103 | 2,971 | 3,272 | 2,209 | 1,800 | Upgrade
|
| EBIT | -10,791 | -12,911 | -13,873 | -10,187 | -4,759 | Upgrade
|
| EBIT Margin | -35.25% | -48.04% | -68.35% | -58.38% | -29.40% | Upgrade
|
| Advertising Expenses | 208.38 | - | - | - | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.